Título Abreviado: ECM 23/1869 ALPHA2
Investigador Principal: Alejandro Martín García Sancho
Código EUDRACT:
Código Identificativo: ECI2023/0027

ALLO-501A-201

A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-501A, an Anti-CD19 Allogeneic CAR T Cell Therapy, and ALLO-647, an Anti-CD52 Monoclonal Antibody, in Subjects With Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Estado: ACTIVO

Pin It en Pinterest